Elanco Animal Health
ELAN
153 hedge funds and large institutions have $2.48B invested in Elanco Animal Health in 2018 Q3 according to their latest regulatory filings, with 153 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
19.29% more ownership
Funds ownership: 0% → 19.29% (+19%)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$317M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178M |
| 3 |
Primecap Management
Pasadena,
California
|
+$132M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$115M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$99.1M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GRP
151
Global Retirement Partners
San Rafael,
California
| $5K | +$4.82K | +137 | New |
|
152
Barclays
London,
United Kingdom
| $3K | +$3.52K | +100 | New |
|
|
WA
153
WealthTrust-Arizona
Scottsdale,
Arizona
| $2K | +$1.76K | +50 | New |
|
|
HI
154
Hudock Inc
Williamsport,
Pennsylvania
| $2K | +$2.5K | +71 | New |
|
ELAN Hedge Fund Activity: Q3 2018 in Review
153 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2018, worth a combined $2.48B.
Buyers outnumbered sellers: 153 funds opened new ELAN positions and 0 closed out — a net gain of 153 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $317M.
- 153 institutional investors held Elanco Animal Health (ELAN) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $2.48B of Elanco Animal Health stock for Q3 2018.
- 153 funds opened new Elanco Animal Health positions in Q3 2018 and 0 closed out, a net change of +153 holders.
- The largest Elanco Animal Health buyer in Q3 2018 was Morgan Stanley, an estimated $317M added.
Based on aggregated 13F filings for Q3 2018.